U.S. Earnings Preview: After Market Close March 20

Like
Comment
Favorite

U.S. Earnings Preview: After Market Close March 20

Dow Jones03-21 03:31

This article was automatically generated by Dow Jones using technology from Automated Insights.

The following companies are among those expected to report their latest financial results after the market closes.

Aura Biosciences Inc.'s fourth-quarter EPS is forecast at a loss of 41 cents, compared with a loss of 52 cents in the prior-year period. Adjusted EPS is forecast at a loss of 43 cents.

Neurogene Inc.'s fourth-quarter EPS is forecast at a loss of $1.27, compared with a loss of 24 cents in the prior-year period. Adjusted EPS is forecast at a loss of $1.24.

Quince Therapeutics Inc.'s fourth-quarter EPS is forecast at a loss of 12 cents, compared with a loss of 28 cents in the prior-year period. Adjusted EPS is forecast at a loss of 17 cents.

Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.

(END) Dow Jones Newswires

March 20, 2026 15:31 ET (19:31 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2621595827?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-21 03:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2621595827","market":"nz","top_or_hot":-1,"title":"U.S. Earnings Preview: After Market Close March 20","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     The following companies are among those expected to report their latest financial results after the market closes. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/AURA\">Aura Biosciences</a> Inc.'s fourth-quarter EPS is forecast at a loss of 41 cents, compared with a loss of 52 cents in the prior-year period. Adjusted EPS is forecast at a loss of 43 cents. \n</p>\n<p>\n  Neurogene Inc.'s fourth-quarter EPS is forecast at a loss of $1.27, compared with a loss of 24 cents in the prior-year period. Adjusted EPS is forecast at a loss of $1.24. \n</p>\n<p>\n  Quince <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc.'s fourth-quarter EPS is forecast at a loss of 12 cents, compared with a loss of 28 cents in the prior-year period. Adjusted EPS is forecast at a loss of 17 cents. \n</p>\n<p>\n  Generated from Dow Jones Calendar Live with data from Dow Jones and Factset. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 20, 2026 15:31 ET (19:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Earnings Preview: After Market Close March 20</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Earnings Preview: After Market Close March 20\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-21 03:31</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     The following companies are among those expected to report their latest financial results after the market closes. \n</p>\n<p>\n  <a href=\"https://laohu8.com/S/AURA\">Aura Biosciences</a> Inc.'s fourth-quarter EPS is forecast at a loss of 41 cents, compared with a loss of 52 cents in the prior-year period. Adjusted EPS is forecast at a loss of 43 cents. \n</p>\n<p>\n  Neurogene Inc.'s fourth-quarter EPS is forecast at a loss of $1.27, compared with a loss of 24 cents in the prior-year period. Adjusted EPS is forecast at a loss of $1.24. \n</p>\n<p>\n  Quince <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc.'s fourth-quarter EPS is forecast at a loss of 12 cents, compared with a loss of 28 cents in the prior-year period. Adjusted EPS is forecast at a loss of 17 cents. \n</p>\n<p>\n  Generated from Dow Jones Calendar Live with data from Dow Jones and Factset. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 20, 2026 15:31 ET (19:31 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AURA","symbol_name":"Aura Biosciences, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2621595827","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2621595827","pubTimestamp":1774035060,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results after the market closes.Aura Biosciences Inc.'s fourth-quarter EPS is forecast at a loss of 41 cents, compared with a loss of 52 cents in the prior-year period. Adjusted EPS is forecast at a loss of 43 cents.Neurogene Inc.'s fourth-quarter EPS is forecast at a loss of $1.27, compared with a loss of 24 cents in the prior-year period. Adjusted EPS is forecast at a loss of $1.24.Quince Therapeutics Inc.'s fourth-quarter EPS is forecast at a loss of 12 cents, compared with a loss of 28 cents in the prior-year period. Adjusted EPS is forecast at a loss of 17 cents.Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AURA":"Aura Biosciences, Inc.","QNCX":"Quince Therapeutics, Inc.","NGNE":"NEUROGENE INC","BK4139":"生物科技"},"translate_title":"美国财报预览：3月20日收盘后","themeId":"8603dabb40994e59ac78c04c930c0d49","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NGNE":0.9,"AURA":0.9,"QNCX":0.9},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     The following companies are among those expected to report their latest financial results after the market closes. \n\n\nAura Biosciences Inc.'s fourth-quarter EPS is forecast at a loss of 41 cents, compared with a loss of 52 cents in the prior-year period. Adjusted EPS is forecast at a loss of 43 cents. \n\n\n  Neurogene Inc.'s fourth-quarter EPS is forecast at a loss of $1.27, compared with a loss of 24 cents in the prior-year period. Adjusted EPS is forecast at a loss of $1.24. \n\n\n  Quince Therapeutics Inc.'s fourth-quarter EPS is forecast at a loss of 12 cents, compared with a loss of 28 cents in the prior-year period. Adjusted EPS is forecast at a loss of 17 cents. \n\n\n  Generated from Dow Jones Calendar Live with data from Dow Jones and Factset. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 20, 2026 15:31 ET (19:31 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"preview","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}